Rare Malignancies - Day 1 - 2 March 2023
Welcome & Introduction
How I Treat ES-SCLC with Durvalamb-Real world experience
Optimizing Treatment Decisions in Unresectable Stage-III NSCLC-A Case Study
Medical Oncology-Neuroendocrine Tumors in the Lung
Pathology-Neuroendocrine tumors in the lung
Nuclear Medicine-Diagnosis and Therapeutic Aspects
Case Based Panel Discussion
Expert Comment
Closing remarks